| 000 | 01435 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512041145.0 | ||
| 264 | 0 | _c19881202 | |
| 008 | 198812s 0 0 eng d | ||
| 022 | _a0361-8609 | ||
| 024 | 7 |
_a10.1002/ajh.2830290205 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBalaban, E P | |
| 245 | 0 | 0 |
_aTreatment of "poor risk" acute nonlymphocytic leukemia with continuously infused low-dose cytosine arabinoside. _h[electronic resource] |
| 260 |
_bAmerican journal of hematology _cOct 1988 |
||
| 300 |
_a79-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBone Marrow _xpathology |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aKaryotyping |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRemission Induction |
| 700 | 1 | _aCox, J V | |
| 700 | 1 | _aSchneider, N R | |
| 700 | 1 | _aHarth, C A | |
| 700 | 1 | _aHaley, B B | |
| 700 | 1 | _aSheehan, R | |
| 700 | 1 | _aFrenkel, E P | |
| 773 | 0 |
_tAmerican journal of hematology _gvol. 29 _gno. 2 _gp. 79-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.2830290205 _zAvailable from publisher's website |
| 999 |
_c3195090 _d3195090 |
||